Literature DB >> 23540720

Sagittal abdominal diameter as a marker for epicardial adipose tissue in premenopausal women.

Ana Carolina Junqueira Vasques1, José Roberto Matos Souza, Ademar Yamanaka, Maria da Saúde de Oliveira, Fernanda Satake Novaes, José Carlos Pareja, Bruno Geloneze.   

Abstract

OBJECTIVE: Accumulation of epicardial (EAT) adipose tissue is associated with the development of an unfavorable metabolic risk profile. Gold standard methods used to assess this fat depot are not routinely applicable in the clinic. Anthropometric measures, including the sagittal abdominal diameter (SAD), have emerged as surrogate markers of visceral obesity. We determined the relationship between EAT measurement and cardiometabolic risk parameters and the potential use of the SAD, compared with other anthropometric parameters, as a practical estimation of EAT. MATERIALS/
METHODS: Sixty-seven premenopausal women were evaluated. The anthropometric parameters that were measured included waist circumference, SAD, body mass index and waist-to-hip ratio. EAT was determined by echocardiogram. Visceral adipose tissue (VAT) was determined by abdominal ultrasound. Insulin sensitivity was assessed by the hyperglycemic clamp.
RESULTS: The accumulation of EAT was correlated with impaired insulin sensitivity and decreased adiponectin. All of the anthropometric measurements were correlated with EAT. Interestingly, EAT was most significantly correlated with the SAD. From the ROC analysis, we found that the SAD measurements were very accurate, presenting the highest area under the curve for EAT (0.81; p<0.01) when compared with the other measurements. In the multiple linear regression analysis, EAT was moderately predicted by the SAD (R²=0.25; p<0.001).
CONCLUSION: SAD, a simple anthropometric measure, accurately estimated EAT and thus represents a clinically useful non-invasive marker that can identify patients with EAT accumulation.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23540720     DOI: 10.1016/j.metabol.2013.01.022

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

1.  Epicardial and pericardial fat in type 2 diabetes: favourable effects of biliopancreatic diversion.

Authors:  Ana Carolina Junqueira Vasques; José Carlos Pareja; José Roberto Mattos Souza; Ademar Yamanaka; Maria da Saúde de Oliveira; Fernanda Satake Novaes; Élinton Adami Chaim; Francesca Piccinini; Chiara Dalla Man; Claudio Cobelli; Bruno Geloneze
Journal:  Obes Surg       Date:  2015-03       Impact factor: 4.129

2.  Association of pericardial fat volume with coronary atherosclerotic disease assessed by CT angiography.

Authors:  H Nafakhi; A Al-Mosawi; H Al-Nafakh; N Tawfeeq
Journal:  Br J Radiol       Date:  2014-04-16       Impact factor: 3.039

3.  Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort study.

Authors:  Petter K Nyström; Axel C Carlsson; Karin Leander; Ulf de Faire; Mai-Lis Hellenius; Bruna Gigante
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

4.  Sagittal Abdominal Diameter as a Surrogate Marker of Insulin Resistance in an Admixtured Population--Brazilian Metabolic Syndrome Study (BRAMS).

Authors:  Ana Carolina J Vasques; Roberta S L Cassani; Adriana C e Forti; Brunna S Vilela; José Carlos Pareja; Marcos Antonio Tambascia; Bruno Geloneze
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

5.  The HOMA-Adiponectin (HOMA-AD) Closely Mirrors the HOMA-IR Index in the Screening of Insulin Resistance in the Brazilian Metabolic Syndrome Study (BRAMS).

Authors:  Brunna Sullara Vilela; Ana Carolina Junqueira Vasques; Roberta Soares Lara Cassani; Adriana Costa E Forti; José Carlos Pareja; Marcos Antonio Tambascia; Bruno Geloneze
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.